Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. (BPL) is a leading biopharmaceutical company headquartered in the United Kingdom. Established in 1983, BPL has made significant strides in the development and manufacture of high-quality plasma-derived therapies, primarily serving patients with rare and chronic conditions. With operational facilities in the UK and a growing presence in international markets, BPL is committed to advancing healthcare through innovative solutions. The company’s core products include immunoglobulins, clotting factors, and albumin, all distinguished by their rigorous quality standards and commitment to patient safety. BPL's dedication to research and development has positioned it as a trusted partner in the biopharmaceutical industry, recognised for its contributions to patient care and its robust pipeline of therapies. With a focus on excellence and innovation, Bio Products Laboratory Ltd. continues to enhance its market position and deliver impactful healthcare solutions globally.
DitchCarbon Score
How does Bio Products Laboratory Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bio Products Laboratory Ltd.'s score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bio Products Laboratory Ltd.'s reported carbon emissions
Bio Products Laboratory Ltd., headquartered in Great Britain, currently does not report any specific carbon emissions data, as there are no available figures for kg CO2e emissions. Additionally, the company has not established any documented reduction targets or climate pledges. As such, there are no specific commitments or initiatives outlined regarding their carbon footprint or climate action strategies. In the absence of emissions data and reduction initiatives, it is important to note that many organisations in the biopharmaceutical sector are increasingly focusing on sustainability and climate commitments. This trend often includes setting science-based targets and participating in global initiatives to reduce greenhouse gas emissions. However, without specific information from Bio Products Laboratory Ltd., it is unclear how they align with these industry standards.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bio Products Laboratory Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
